It’s emerging in all cancers, but particularly in the MPNs, that “genomics is everything” according to Professor Andrew Perkins, an expert in myeloproliferative neoplasms (MPN).
Diagnosed with PV and ET at the age of 18, Sharon was having treatment when she fell pregnant with the first of her three healthy children in 2000.
A lot of ‘world firsts’ are involved in an Australian clinical trial that is taking a precision medicine approach to treating CMML, a neglected and serious rare blood cancer that is poorly understood.
Dr Forsyth is passionate about what MPN patients can do to improve their health.
Sue Taylor has been curious about whether she may in fact have a different type of MPN to her diagnosis.
After losing her dad to MDS, and her brother’s diagnosis just a month before hers, Christine Heath’s family underwent genomic testing to understand whether their MDS could be hereditary.
Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.
Jennie and Russell Wigginton were planning for baby number two, when Jennie was diagnosed "out of the blue".
Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.
